@InzenTx

Harnessing the power of Thanokine Biology

Joined May 2019
  • Tweets4
  • Following1
  • Followers42
LISTEN: Flagship Managing Partner Doug Cole and Flagship CEO-Partner and CEO of @InzenTx Volker Herrmann discuss cell turnover, why it’s so important to health and disease, and its implications for @InzenTx's pioneering research and drug development. flagshippioneering.com/podca…
2
8
Billions of cells die in our bodies every day. It turns out other cells are paying close attention for clues as to how & why. Learn more about the new insights and vast new therapeutic opportunities we're creating. @FlagshipPioneer flagshippioneering.com/stori…

Thanokine Signaling

How cells respond to inputs from dying cells is a rich and untapped source of insights into health and disease. Illustration by Mary Jo Roberts-Braisted

flagshippioneering.com
2
Read more about Inzen and Thanokine Biology here! endpts.com/flagship-christen…

Flagship christens the latest startup to join the drug discovery fleet, this time focused on the...

A few years ago, Flagship managing partner Doug Cole began to pick at the notion that cell death could offer a rich source of information on new drugs. After all ...

endpoints.news
2
4
We are excited to officially unveil Inzen Therapeutics. Created by @FlagshipPioneer we are pioneering a new class of medicines based on Thanokine™ Biology. Read more about our discoveries here and follow us to keep up to date on our progress! prnewswire.com/news-releases…

Flagship Pioneering Unveils Inzen Therapeutics

/PRNewswire/ -- Flagship Pioneering, a life science platforms company, today announced the unveiling of Inzen Therapeutics. Flagship created Inzen in 2017 to...

prnewswire.com
1
5
Load more